A new weight-loss pill is here, and it could reshape the GLP-1 market
Lilly’s new pill, Foundayo, enters a fast-growing market currently dominated by Novo Nordisk’s Wegovy. A new GLP-1 pill is about to hit the market. On Wednesday, Eli Lilly and Co. announced that its new GLP-1 pill, Foundayo, was approved by the Food and Drug Administration (FDA) for use in adults w...